Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation.
Sign Up to like & getrecommendations! Published in 2017 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2017.06.015
Abstract: BACKGROUND Spasticity is a common symptom of multiple sclerosis (MS) affecting about 80% of MS patients. Numerous lines of evidence suggest that spasticity due to its complexity is not adequately managed with conventional anti-spastic therapies.… read more here.
Keywords: overview last; sativex; spasticity; management ... See more keywords
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008826
Abstract: Introduction: Currently, none of the available multiple sclerosis (MS) disease-modifying medications has been shown to stop or reverse gait disability. Recently, the nabiximols has been tested for the treatment of spasticity and walking impairment in… read more here.
Keywords: role sativex; sativex; training; multiple sclerosis ... See more keywords